Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
15 studies found for:    "Noonan syndrome 1"
Show Display Options
RSS Create an RSS feed from your search for:
"Noonan syndrome 1"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's Syndrome
Condition: Noonan Syndrome
Intervention: Drug: MAXOMAT ®, biosynthetic growth hormone
2 Not yet recruiting Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan Syndrome
Condition: Noonan Syndrome
Interventions: Drug: Simvastatin;   Drug: Placebo
3 Terminated Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome
Condition: Noonan Syndrome
Intervention: Drug: rhIGF-1/rhIGFBP-3
4 Completed Somatropin Effect on Linear Growth and Final Height in Subjects With Noonan Syndrome
Conditions: Genetic Disorder;   Noonan Syndrome
Intervention: Drug: somatropin
5 Active, not recruiting Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome
Conditions: Genetic Disorder;   Noonan Syndrome
Intervention: Drug: somatropin
6 Not yet recruiting Hormonal Sensitivity in Patients With Noonan and LEOPARD Syndromes
Conditions: Noonan Syndrome;   LEOPARD Syndrome
Intervention:
7 Completed Study of Metabolic Modifications in Children With Noonan Syndrome
Condition: Child Syndrome
Intervention: Other: Oral Glucose tolerance test
8 Withdrawn Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MEK162 in Noonan Syndrome Hypertrophic Cardiomyopathy
Condition: Cardiomegaly
Intervention: Drug: MEK162
9 Completed Genetic Testing of Noonan Subjects Previously Treated With Norditropin®. An Extension to Trial GHNOO-1658
Conditions: Genetic Disorder;   Noonan Syndrome
Intervention: Drug: somatropin
10 Completed Dengue Virus NS1 Antigen (Bio-Rad) Clinical Protocol
Condition: Mass Screening
Intervention: Device: Bio-Rad Platelia Dengue NS1 Ag test
11 Active, not recruiting Sensitivity Study of Diagnostic for Early Detection of Dengue Infection
Condition: Infectious Diseases
Intervention:
12 Completed Specificity Study of Diagnostic for Early Detection of Dengue Infection
Condition: Infectious Diseases
Intervention:
13 Completed Observational Prospective Study on Patients Treated With Norditropin®
Conditions: Growth Hormone Disorder;   Growth Hormone Deficiency in Children;   Adult Growth Hormone Deficiency;   Genetic Disorder;   Turner Syndrome;   Foetal Growth Problem;   Small for Gestational Age;   Chronic Kidney Disease;   Chronic Renal Insufficiency;   Noonan Syndrome
Intervention: Drug: somatropin
14 Recruiting Familial Investigations of Childhood Cancer Predisposition
Conditions: Acute Leukemia;   Adenomatous Polyposis;   Adrenocortical Carcinoma;   AML;   BAP1 Tumor Predisposition Syndrome;   Carney Complex;   Choroid Plexus Carcinoma;   Constitutional Mismatch Repair Deficiency Syndrome;   Diamond-Blackfan Anemia;   DICER1 Syndrome;   Dyskeratosis Congenita;   Emberger Syndrome;   Familial Acute Myeloid Leukaemia;   Familial Adenomatous Polyposis;   Fanconi Anemia;   Familial Cancer;   Familial Wilms Tumor;   Familial Neuroblastoma;   GIST;   Hereditary Breast and Ovarian Cancer;   Hereditary Paraganglioma-Pheochromocytoma Syndrome;   Hodgkin Lymphoma;   Juvenile Polyposis;   Li-Fraumeni Syndrome;   Lynch Syndrome;   MDS;   Melanoma Syndrome;   Multiple Endocrine Neoplasia Type 1;   Multiple Endocrine Neoplasia Type 2;   Neuroblastoma;   Neurofibromatosis Type 1;   Neurofibromatosis Type II;   Nevoid Basal Cell Carcinoma Syndrome;   Non Hodgkin Lymphoma;   Noonan Syndrome and Other Rasopathy;   Overgrowth Syndromes;   Pancreatic Cancer;   Peutz-Jeghers Syndrome;   Pheochromocytoma/Paraganglioma;   PTEN Hamartoma Tumor Syndrome;   Retinoblastoma;   Rhabdoid Tumor Predisposition Syndrome;   Rhabdomyosarcoma;   Rothmund-Thomson Syndrome;   Tuberous Sclerosis;   Von Hippel-Lindau Disease
Intervention:
15 Completed Laboratory Diagnosis and Prognosis of Severe Dengue
Condition: Dengue Fever
Intervention:

Study has passed its completion date and status has not been verified in more than two years.